SYBX
Synlogic IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.49M
P/E Ratio
—
EPS
$-0.08
Beta
0.49
52W High
$1.96
52W Low
$0.54
50-Day MA
$0.63
200-Day MA
$1.24
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Synlogic Inc
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic drugs to treat cancer, inflammatory, and metabolic diseases in the United States. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-3.19M |
| Operating Margin | 0.00% |
| Return on Equity | -8.17% |
| Return on Assets | -12.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.01 |
| Price-to-Book | 0.59 |
| Price-to-Sales (TTM) | 936.86 |
| EV/Revenue | 55.4 |
| EV/EBITDA | 0.18 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $11.70M |
| Float | $4.07M |
| % Insiders | 21.39% |
| % Institutions | 65.56% |
Data last updated: 4/9/2026